HNF1A mutations are found to dysregulate RNA splicing in pancreatic cells, thereby contributing to the onset of diabetes.

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical trial.

If you experience a loss of appetite or feel full after eating very little, this also may be a sign of pancreatic cancer.

A proof-of-concept study finds that donated insulin-producing cells can be genetically modified to avoid provoking the recipient's immune system.

UCSF researchers have pinpointed a crucial brain receptor that helps immune cells called microglia clear out toxic amyloid ...

A large prospective study validated a long-suspected association between diabetes and pancreatic cancer.Individuals with ...